Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for determining related substances of propofol tenofovir by high performance liquid chromatography

A technology of tenofovir and related substances, applied in the field of drug analysis, can solve the problems of difficult separation of by-products such as diastereoisomers and undetected potential impurities, so as to shorten the elution time, ensure safe drug use, and generality high effect

Pending Publication Date: 2022-01-25
BEIJING SIHUAN PHARMA +3
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The diastereoisomers and other by-products produced in the reaction process of this route are difficult to separate, and it is necessary to establish a detection method with good applicability for quality control of the related substances in the tenofovir alafenamide API and its preparations
[0007] CN111189947A discloses a method for separating and detecting tenofovir alafenamide impurities, using methanol and acidic aqueous solution as mobile phase gradient elution, separating and detecting specific isomer impurities, but not detecting potential impurities, such as degradation impurities, Process impurities, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for determining related substances of propofol tenofovir by high performance liquid chromatography
  • Method for determining related substances of propofol tenofovir by high performance liquid chromatography
  • Method for determining related substances of propofol tenofovir by high performance liquid chromatography

Examples

Experimental program
Comparison scheme
Effect test

experiment example 1

[0039] Experimental example 1 System suitability inspection

[0040] Take an appropriate amount of impurity 1-11 reference substance and tenofovir alafenamide (TAF) reference substance, add phase A to dissolve and quantitatively dilute to form a mixed solution, wherein the final mixture of impurities 1-7 and tenofovir alafenamide The concentration was 2 μg / ml, and the final concentration of impurities 8-11 was 1 μg / ml, as a system suitability solution.

[0041] Take the system suitability solution and inject it into the liquid chromatograph, and the chromatographic conditions are as follows:

[0042] Chromatographic column: Thermo Hypersil BDS C18 (250mm×4.6mm, 5μm)

[0043] Phase A: [tetrahydrofuran-acetonitrile (7:3)]-0.02mol / L dipotassium hydrogen phosphate buffer (pH6.0) (1:99)

[0044] Phase B: [tetrahydrofuran-acetonitrile (7:3)]-0.02mol / L dipotassium hydrogen phosphate buffer (pH6.0) (50:50)

[0045] The detection wavelength is 260nm, the flow rate: 1.0ml / min, the ...

Embodiment 2

[0051] Example 2 Other methodological investigations

[0052] (1) Quantitation limit and detection limit

[0053] The limit of quantification and detection sensitivity of TAF and each impurity all meet the requirements (see Table 4).

[0054] Table 4

[0055]

[0056]

[0057] (2) Linearity and range

[0058] Within the specified measurement range (impurity 1-3, 5, 8-11: 1-30μg / ml, impurity 4: 1-32μg / ml, impurity 6-7: 0.8-24μg / ml, TAF: 0.9-27μg / ml ), the peak area of ​​TAF and each impurity has a good linear relationship with the concentration, and r is greater than 0.99.

[0059] (3) Precision and repeatability

[0060] 6 samples were prepared in parallel by 2 different experimenters for detection. The RSDs with impurity content > 0.1% were all less than 20%, and the RSDs with impurity content ≤ 0.1% were all less than 50%. The detection method of the present invention has good precision and repeatability .

[0061] (4) Recovery rate and accuracy

[0062] The r...

Embodiment 3

[0069] Example 3 Detection of related substances in TAF samples

[0070] Three batches of TAF samples were synthesized by the synthesis method in CHAPMAN et al. (Nucleosides and Nucleic Acids, 20(4-7):621-628, 20010401) as samples to be tested.

[0071] Accurately weigh an appropriate amount of the sample to be tested, add phase A to dissolve and quantitatively dilute to make a 1mg / ml solution as the test solution. Precisely measure an appropriate amount of the test solution, and quantitatively dilute it with phase A to make a 1 μg / ml solution as a control solution.

[0072] Accurately measure control solution and need testing solution, inject liquid chromatograph, adopt chromatographic condition 1 and chromatographic condition 2 in Table 6 to detect respectively, and the results are shown in Table 7.

[0073] Table 6 Chromatographic conditions

[0074]

[0075]

[0076] Table 7

[0077]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention provides a method for determining related substances of propofol tenofovir by high performance liquid chromatography, and the high performance liquid chromatography conditions are as follows: a C18 silica gel chromatographic column is used, the detection wavelength is 260 nm, the flow velocity is 1.0 ml / min, the column temperature is 25-30 DEG C, the sample size is 10-50 [mu] l, the mobile phase is composed of a phase A and a phase B, wherein the volume ratio of a weakly acidic buffer salt solution to an organic solvent in the phase A is (80.0-99.9): 1, and the volume ratio of the weakly acidic buffer salt solution to the organic solvent in the phase B is (40-60): (60-40), and gradient elution is carried out. According to the method, a C18 silica gel column with high universality is selected to perform high performance liquid chromatography detection on the related substances of the propofol tenofovir, elution conditions are optimized, various related substances can be detected, and the method has the advantages of being easy and convenient to operate, capable of remarkably shortening elution time, high in detection sensitivity, good in separation degree, high in universality, low in cost and the like, is used for controlling the drug quality of the propofol tenofovir and the preparation thereof, and guarantees safe medication.

Description

technical field [0001] The invention belongs to the field of drug analysis, in particular to a method for measuring tenofovir alafenamide (TAF) and its related substances by high performance liquid chromatography (HPLC method). Background technique [0002] Tenofovir alafenamide (TAF for short) is a nucleoside reverse transcriptase inhibitor, a prodrug of tenofovir, used for the treatment of chronic hepatitis B infection with compensated liver disease. Compared with tenofovir disoproxil, this product has stronger antiviral activity and can enter lymphoid tissue more effectively. [0003] [0004] (Nucleosides and Nucleic Acids, 20 (4-7): 621-628, 20010401) such as CHAPMAN discloses the synthetic method of tenofovir alafenamide, and the steps are as follows: [0005] [0006] The by-products such as diastereoisomers produced during the reaction of this route are difficult to separate, and it is necessary to establish a detection method with good applicability to contro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G01N30/88G01N30/06
CPCG01N30/88G01N30/06
Inventor 俞黎华张彤邓声菊王田园徐艳君
Owner BEIJING SIHUAN PHARMA